$GHDX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GENOMIC HEALTH INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GENOMIC HEALTH INC. Get notifications about new insider transactions in GENOMIC HEALTH INC for free.
Page: < prev 1 ... 18 19 20 21 22 23 24 25 26 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.15 | 583 | 15,245 | 159,506 | 158.9 K to 159.5 K (+0.37 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.14 | 607 | 15,868 | 158,923 | 158.3 K to 158.9 K (+0.38 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.17 | 1,045 | 27,346 | 158,316 | 157.3 K to 158.3 K (+0.66 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.35 | 1 | 26 | 194,415 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.30 | 3 | 79 | 194,414 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.25 | 45 | 1,181 | 194,411 | 194.4 K to 194.4 K (+0.02 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.10 | 7 | 183 | 194,366 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.11 | 5 | 131 | 194,359 | 194.4 K to 194.4 K (0.00 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.15 | 15 | 392 | 194,354 | 194.3 K to 194.4 K (+0.01 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.14 | 16 | 418 | 194,339 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 09 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 26.17 | 27 | 707 | 194,323 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 77,868 | |
| Jun 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 26.18 | 2,500 | 65,452 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
| Jun 08 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.51 | 34,379 | 945,777 | 5,855,797 | 5.8 M to 5.9 M (+0.59 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.47 | 37,092 | 1,018,799 | 5,821,418 | 5.8 M to 5.8 M (+0.64 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.48 | 36,056 | 990,949 | 5,784,326 | 5.7 M to 5.8 M (+0.63 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.46 | 18,983 | 521,286 | 5,748,270 | 5.7 M to 5.7 M (+0.33 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 27.04 | 55,183 | 1,491,922 | 5,729,287 | 5.7 M to 5.7 M (+0.97 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.51 | 821 | 22,586 | 157,271 | 156.5 K to 157.3 K (+0.52 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.47 | 885 | 24,308 | 156,450 | 155.6 K to 156.5 K (+0.57 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.48 | 957 | 26,302 | 155,565 | 154.6 K to 155.6 K (+0.62 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.46 | 504 | 13,840 | 154,608 | 154.1 K to 154.6 K (+0.33 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 27.04 | 1,464 | 39,581 | 154,104 | 152.6 K to 154.1 K (+0.96 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.51 | 21 | 578 | 194,296 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.47 | 23 | 632 | 194,275 | 194.3 K to 194.3 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.48 | 22 | 605 | 194,252 | 194.2 K to 194.3 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.46 | 12 | 330 | 194,230 | 194.2 K to 194.2 K (+0.01 %) |
| Jun 01 2011 | GHDX | GENOMIC HEALTH INC | Baker Bros. Capital (GP), LLC | Director | Buy | P | 27.04 | 34 | 919 | 194,218 | 194.2 K to 194.2 K (+0.02 %) |
| May 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 30,000 | |
| May 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 25.55 | 5,000 | 127,773 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
| May 26 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
| May 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 26.48 | 1,000 | 26,479 | 19,900 | 20.9 K to 19.9 K (-4.78 %) |
| May 11 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.72 | 10,000 | 267,202 | 1,531,146 | 1.5 M to 1.5 M (-0.65 %) |
| May 11 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.59 | 10,000 | 265,911 | 1,541,146 | 1.6 M to 1.5 M (-0.64 %) |
| May 11 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 80,368 | |
| May 11 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 25.93 | 2,500 | 64,834 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
| May 11 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
| Apr 29 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Option Exercise | M | 1.33 | 2,000 | 2,653 | 15,346 | |
| Apr 29 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Sell | S | 26.04 | 2,000 | 52,073 | 6,149 | 8.1 K to 6.1 K (-24.54 %) |
| Apr 29 2011 | GHDX | GENOMIC HEALTH INC | LIVINGSTON RANDALL S | Director | Buy | M | 1.33 | 2,000 | 2,653 | 8,149 | 6.1 K to 8.1 K (+32.53 %) |
| Apr 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 35,000 | |
| Apr 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 25.38 | 5,000 | 126,908 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
| Apr 27 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
| Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 25.32 | 1,000 | 25,319 | 20,900 | 21.9 K to 20.9 K (-4.57 %) |
| Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 9.39 | 4,000 | 37,560 | 23,347 | |
| Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 9.39 | 4,000 | 37,560 | 27,347 | |
| Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 25.64 | 4,000 | 102,573 | 10,000 | 14 K to 10 K (-28.57 %) |
| Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 9.39 | 4,000 | 37,560 | 14,000 | 10 K to 14 K (+40.00 %) |
| Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 25.33 | 4,000 | 101,317 | 10,000 | 14 K to 10 K (-28.57 %) |
| Apr 18 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 9.39 | 4,000 | 37,560 | 14,000 | 10 K to 14 K (+40.00 %) |
| Apr 13 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 25.92 | 10,000 | 259,185 | 1,561,146 | 1.6 M to 1.6 M (-0.64 %) |
| Apr 13 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 26.01 | 10,000 | 260,053 | 1,571,146 | 1.6 M to 1.6 M (-0.63 %) |
| Apr 07 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 5,000 | 6,650 | 82,868 | |
| Apr 07 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 26.91 | 5,000 | 134,572 | 7,750 | 12.8 K to 7.8 K (-39.22 %) |
| Apr 07 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Grant | A | 1.33 | 5,000 | 6,650 | 12,750 | 7.8 K to 12.8 K (+64.52 %) |
| Apr 05 2011 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Grant | A | 24.60 | 406 | 9,988 | 406 | 0 to 406 |
| Apr 05 2011 | GHDX | GENOMIC HEALTH INC | GRAHAM GINGER L | Director | Grant | A | 24.60 | 406 | 9,988 | 406 | 0 to 406 |
| Apr 05 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Grant | A | 24.60 | 406 | 9,988 | 406 | 0 to 406 |
| Apr 05 2011 | GHDX | GENOMIC HEALTH INC | Cohen Fred E | Director | Grant | A | 24.60 | 406 | 9,988 | 49,091 | 48.7 K to 49.1 K (+0.83 %) |
| Apr 05 2011 | GHDX | GENOMIC HEALTH INC | BYERS BROOK H | Director | Grant | A | 24.60 | 406 | 9,988 | 406 | 0 to 406 |
| Mar 28 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 40,000 | |
| Mar 28 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 24.45 | 5,000 | 122,254 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
| Mar 28 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
| Mar 23 2011 | GHDX | GENOMIC HEALTH INC | MYERS WOODROW A JR | Director | Sell | J | 0.00 | 12,000 | 0 | 0 | 12 K to 0 (-100.00 %) |
| Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 23.79 | 1,000 | 23,787 | 21,900 | 22.9 K to 21.9 K (-4.37 %) |
| Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 9.39 | 4,000 | 37,560 | 31,347 | |
| Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 9.39 | 4,000 | 37,560 | 35,347 | |
| Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 23.81 | 4,000 | 95,256 | 296,916 | 300.9 K to 296.9 K (-1.33 %) |
| Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 9.39 | 4,000 | 37,560 | 300,916 | 296.9 K to 300.9 K (+1.35 %) |
| Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 24.77 | 4,000 | 99,098 | 296,916 | 300.9 K to 296.9 K (-1.33 %) |
| Mar 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 9.39 | 4,000 | 37,560 | 300,916 | 296.9 K to 300.9 K (+1.35 %) |
| Mar 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 25.64 | 10,000 | 256,372 | 1,581,146 | 1.6 M to 1.6 M (-0.63 %) |
| Mar 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 25.61 | 10,000 | 256,123 | 1,591,146 | 1.6 M to 1.6 M (-0.62 %) |
| Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.56 | 20,000 | 511,150 | 5,674,104 | 5.7 M to 5.7 M (+0.35 %) |
| Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.22 | 49,056 | 1,286,165 | 5,654,104 | 5.6 M to 5.7 M (+0.88 %) |
| Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.17 | 1,800 | 47,097 | 5,605,048 | 5.6 M to 5.6 M (+0.03 %) |
| Mar 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 87,868 | |
| Mar 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | S | 25.23 | 2,500 | 63,072 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
| Mar 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Grant | A | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.13 | 50 | 1,256 | 152,640 | 152.6 K to 152.6 K (+0.03 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 24.90 | 6,715 | 167,204 | 152,590 | 145.9 K to 152.6 K (+4.60 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.39 | 955 | 24,249 | 145,875 | 144.9 K to 145.9 K (+0.66 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.40 | 537 | 13,642 | 144,920 | 144.4 K to 144.9 K (+0.37 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.44 | 1,133 | 28,827 | 144,383 | 143.3 K to 144.4 K (+0.79 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.50 | 258 | 6,578 | 143,250 | 143 K to 143.3 K (+0.18 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.13 | 1,826 | 45,887 | 5,603,248 | 5.6 M to 5.6 M (+0.03 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.90 | 243,285 | 6,057,797 | 5,601,422 | 5.4 M to 5.6 M (+4.54 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.39 | 34,592 | 878,343 | 5,358,137 | 5.3 M to 5.4 M (+0.65 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.40 | 19,463 | 494,446 | 5,323,545 | 5.3 M to 5.3 M (+0.37 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.44 | 41,041 | 1,044,227 | 5,304,082 | 5.3 M to 5.3 M (+0.78 %) |
| Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.50 | 9,359 | 238,618 | 5,263,041 | 5.3 M to 5.3 M (+0.18 %) |
| Mar 04 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 25.45 | 23,749 | 604,412 | 37,552 | 61.3 K to 37.6 K (-38.74 %) |
| Mar 04 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | S | 25.45 | 10,571 | 269,032 | 19,358 | 29.9 K to 19.4 K (-35.32 %) |
| Mar 04 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 8,753 | 0 | 17,757 | 9 K to 17.8 K (+97.21 %) |
| Mar 04 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Buy | J | 0.00 | 4,300 | 0 | 8,726 | 4.4 K to 8.7 K (+97.15 %) |
| Mar 04 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | J | 0.00 | 10,109 | 0 | 20,838 | 30.9 K to 20.8 K (-32.67 %) |
| Mar 04 2011 | GHDX | GENOMIC HEALTH INC | COLELLA SAMUEL D | Director | Sell | J | 0.00 | 505,571 | 0 | 1,082,174 | 1.6 M to 1.1 M (-31.84 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.16 | 46,367 | 1,212,826 | 5,253,682 | 5.2 M to 5.3 M (+0.89 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.00 | 28,602 | 743,546 | 5,207,315 | 5.2 M to 5.2 M (+0.55 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.56 | 18,986 | 485,237 | 5,178,713 | 5.2 M to 5.2 M (+0.37 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.57 | 23,545 | 601,944 | 5,159,727 | 5.1 M to 5.2 M (+0.46 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.54 | 681 | 17,393 | 5,136,182 | 5.1 M to 5.1 M (+0.01 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.14 | 23,495 | 590,685 | 5,135,501 | 5.1 M to 5.1 M (+0.46 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.04 | 18,661 | 467,333 | 5,112,006 | 5.1 M to 5.1 M (+0.37 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.16 | 1,280 | 33,481 | 142,992 | 141.7 K to 143 K (+0.90 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 26.00 | 789 | 20,511 | 141,712 | 140.9 K to 141.7 K (+0.56 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.56 | 524 | 13,392 | 140,923 | 140.4 K to 140.9 K (+0.37 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.57 | 650 | 16,618 | 140,399 | 139.7 K to 140.4 K (+0.47 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.54 | 19 | 485 | 139,749 | 139.7 K to 139.7 K (+0.01 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.14 | 649 | 16,316 | 139,730 | 139.1 K to 139.7 K (+0.47 %) |
| Mar 02 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 25.04 | 515 | 12,897 | 139,081 | 138.6 K to 139.1 K (+0.37 %) |
| Feb 28 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Option Exercise | M | 9.39 | 5,000 | 46,950 | 45,000 | |
| Feb 28 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Sell | S | 23.27 | 5,000 | 116,325 | 392,778 | 397.8 K to 392.8 K (-1.26 %) |
| Feb 28 2011 | GHDX | GENOMIC HEALTH INC | Shak Steven | Chief Medical Offic ... | Buy | M | 9.39 | 5,000 | 46,950 | 397,778 | 392.8 K to 397.8 K (+1.27 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 24.23 | 13,986 | 338,914 | 5,093,345 | 5.1 M to 5.1 M (+0.28 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.89 | 12,897 | 308,051 | 5,079,359 | 5.1 M to 5.1 M (+0.25 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.95 | 8,195 | 196,230 | 5,066,462 | 5.1 M to 5.1 M (+0.16 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.47 | 24,318 | 570,787 | 5,058,267 | 5 M to 5.1 M (+0.48 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 23.43 | 48,224 | 1,129,811 | 5,033,949 | 5 M to 5 M (+0.97 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 22.87 | 2,393 | 54,726 | 4,985,725 | 5 M to 5 M (+0.05 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 22.88 | 15,333 | 350,821 | 4,983,332 | 5 M to 5 M (+0.31 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 22.88 | 33,009 | 755,163 | 4,967,999 | 4.9 M to 5 M (+0.67 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 24.23 | 386 | 9,354 | 138,566 | 138.2 K to 138.6 K (+0.28 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 23.89 | 356 | 8,503 | 138,180 | 137.8 K to 138.2 K (+0.26 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 23.95 | 226 | 5,412 | 137,824 | 137.6 K to 137.8 K (+0.16 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 23.47 | 671 | 15,750 | 137,598 | 136.9 K to 137.6 K (+0.49 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 23.43 | 1,331 | 31,183 | 136,927 | 135.6 K to 136.9 K (+0.98 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 22.87 | 66 | 1,509 | 135,596 | 135.5 K to 135.6 K (+0.05 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 22.88 | 423 | 9,678 | 135,530 | 135.1 K to 135.5 K (+0.31 %) |
| Feb 25 2011 | GHDX | GENOMIC HEALTH INC | 14159 capital (GP), LLC | Director | Buy | P | 22.88 | 911 | 20,841 | 135,107 | 134.2 K to 135.1 K (+0.68 %) |
| Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Sell | S | 22.51 | 1,000 | 22,506 | 22,900 | 23.9 K to 22.9 K (-4.18 %) |
| Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 9.39 | 4,000 | 37,560 | 39,347 | |
| Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | M | 9.39 | 4,000 | 37,560 | 43,347 | |
| Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 22.64 | 4,000 | 90,579 | 296,916 | 300.9 K to 296.9 K (-1.33 %) |
| Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 9.39 | 4,000 | 37,560 | 300,916 | 296.9 K to 300.9 K (+1.35 %) |
| Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Sell | S | 22.38 | 4,000 | 89,540 | 296,916 | 300.9 K to 296.9 K (-1.33 %) |
| Feb 16 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Buy | M | 9.39 | 4,000 | 37,560 | 300,916 | 296.9 K to 300.9 K (+1.35 %) |
| Feb 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 22.28 | 10,000 | 222,820 | 1,601,146 | 1.6 M to 1.6 M (-0.62 %) |
| Feb 14 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Sell | S | 22.12 | 10,000 | 221,223 | 1,611,146 | 1.6 M to 1.6 M (-0.62 %) |
| Feb 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | M | 1.33 | 2,500 | 3,325 | 90,368 | |
| Feb 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Sell | M | 23.24 | 2,500 | 58,098 | 7,750 | 10.3 K to 7.8 K (-24.39 %) |
| Feb 10 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Buy | M | 1.33 | 2,500 | 3,325 | 10,250 | 7.8 K to 10.3 K (+32.26 %) |
| Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Option Exercise | A | 22.98 | 40,000 | 919,200 | 40,000 | |
| Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Scott Randal W | Executive Chairman | Grant | A | 0.00 | 4,500 | 0 | 1,622,146 | 1.6 M to 1.6 M (-0.28 %) |
| Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Option Exercise | A | 22.98 | 33,000 | 758,340 | 33,000 | |
| Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Schorno Dean L | CFO | Grant | A | 0.00 | 3,900 | 0 | 23,900 | 20 K to 23.9 K (+19.50 %) |
| Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Option Exercise | A | 22.98 | 90,000 | 2,068,200 | 90,000 | |
| Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Popovits Kimberly J | President and CEO | Grant | A | 0.00 | 10,000 | 0 | 296,916 | 286.9 K to 296.9 K (+3.49 %) |
| Jan 31 2011 | GHDX | GENOMIC HEALTH INC | Cole G Bradley | COO | Option Exercise | A | 22.98 | 60,000 | 1,378,800 | 60,000 |